Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models
Ching Leng Tan(IMU University), Dinesh Kumar Chellappan(IMU University), Yinghan Chan(University of Malaya), Piyush Kumar Gupta(INTI International University), Nitin Verma(Chitkara University), Sachin Kumar Singh(Lovely Professional University), Kamal Dua(University of Technology Sydney), Parteek Prasher(University of Petroleum and Energy Studies), Lakshmana Prabu Sakthivel(Anna University, Chennai), Ronan MacLoughlin(Aerogen (Ireland)), Vyoma K. Patel(University of Technology Sydney), Keshav Raj Paudel(University of Technology Sydney), Shvetank Bhatt(MIT World Peace University), Hari Prasad Devkota(Kumamoto University), Mayuren Candasamy(Institute for Research and Development), Thiagarajan Madheswaran(IMU University), Brian G. Oliver(University of Technology Sydney), Deepak Kumar(Shoolini University), Philip M. Hansbro(University of Technology Sydney), Vamshikrishna Malyla(University of Technology Sydney), Amlan Chakraborty(Discovery Institute), Jestin Chellian, Lakshmi Thangavelu(Saveetha University), Niraj Kumar Jha(Chandigarh University), Gaurav Gupta(Gyan Vihar University), Monica Gulati(Lovely Professional University)
Cited by 36
Related Papers
CAR T cells in solid tumors: challenges and opportunities
|Stem Cell Research & Therapy|2021|573
Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention
|Diabetes & Metabolic Syndrome Clinical Research & Reviews|2018|444
Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae)
|Biomolecules|2020|441
Microbiome effects on immunity, health and disease in the lung
|Clinical & Translational Immunology|2017|282
RETRACTED ARTICLE: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
|Stem Cell Research & Therapy|2021|275